First-in-class eczema drug dupilumab now available in Ireland
Life-changing biologic treatment, dupilumab, is now available to people with moderate to severe eczema in Ireland. The HSE has advised that effective from 1st April 2021, reimbursement of dupilumab will be available under High Tech Arrangements for the treatment of moderate-to-severe refractory atopic dermatitis (AD) in adults and adolescents 12 years and older for whom […]
